Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002297
Filing Date
2022-02-28
Accepted
2022-02-28 16:16:03
Documents
94
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rvmd-20211231.htm   iXBRL 10-K 4469043
2 EX-4.3 rvmd-ex4_3.htm EX-4.3 45975
3 EX-23.1 rvmd-ex23_1.htm EX-23.1 2734
4 EX-31.1 rvmd-ex31_1.htm EX-31.1 18859
5 EX-31.2 rvmd-ex31_2.htm EX-31.2 18887
6 EX-32.1 rvmd-ex32_1.htm EX-32.1 9794
7 EX-32.2 rvmd-ex32_2.htm EX-32.2 9810
8 GRAPHIC img26518894_0.jpg GRAPHIC 55262
9 GRAPHIC img26518894_1.jpg GRAPHIC 67258
10 GRAPHIC img26518894_2.jpg GRAPHIC 139398
11 GRAPHIC img26518894_3.jpg GRAPHIC 151260
12 GRAPHIC img26518894_4.jpg GRAPHIC 107587
13 GRAPHIC img26518894_5.jpg GRAPHIC 141149
14 GRAPHIC img26518894_6.jpg GRAPHIC 128513
15 GRAPHIC img26518894_7.jpg GRAPHIC 35141
16 GRAPHIC img26518894_8.jpg GRAPHIC 179792
  Complete submission text file 0000950170-22-002297.txt   17161429

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvmd-20211231_lab.xml EX-101.LAB 670799
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvmd-20211231_cal.xml EX-101.CAL 79526
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvmd-20211231.xsd EX-101.SCH 79525
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvmd-20211231_def.xml EX-101.DEF 331059
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvmd-20211231_pre.xml EX-101.PRE 513807
88 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20211231_htm.xml XML 2838399
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39219 | Film No.: 22689763
SIC: 2836 Biological Products, (No Diagnostic Substances)